ABOUT NEUTRALIZING ANTIBODIES
A VACCINE DOES NOT GUARANTEE IMMUNITY
Intermediate and long-term effectiveness is dependent on many different factors including:
- Brand of Vaccine
- Pre-existing conditions
WANING IMMUNITY OVER TIME
Breakthrough infections on fully vaccinated individuals and surging numbers of infections related to new variants are creating uncertainties for the general public.
The only antibody that prevents the SARS-CoV-2 virus from entering and infecting the cell.
The Neutralizing Antibody Test identifies the presence of these specific antibodies and defines their level of protection*
* FDA EUA approved test. Greater than 30% neutralizing antibodies indicates positive protection against SARS-CoV-2 . Retesting recommended in 120 days in healthy individuals .
TESTING FOR NEUTRALIZING ANTIBODIES
A COMPREHENSIVE IMMUNITY ASSAY FOR SARS-CoV-2*
Neutralizing Antibodies SARS-CoV-2
Neutralizing Antibodies for the Delta Variant*
N1 Fragment Antibody Test**
- Prior COVID-19 infection
- No Prior COVID-19 infection
Test results and specimen registration via the EVE Patient App